Madrigal Pharmaceuticals Inc (MDGL)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Dr. David SoergelExec. VP & Chief Medical Officer | -1.04k | 516.56k | Automatic Disposition | 495.74 | 10.03k | -9.41% |
| 2026-05-22 | Dr. Richard S. LevyIndependent Director | -5.68k | 2.93M | Automatic Disposition | 506.68 - 519.98 | 21.30k | -21.06% |
| 2026-05-18 | Dr. David SoergelExec. VP & Chief Medical Officer | -844.00 | 435.42k | 売り | 515.90 | 11.08k | -7.08% |
| 2026-03-06 | Ms. Mardi C. DierExec. VP & CFO | -646.00 | 279.03k | 売り | 431.94 | 0.00 | -100.00% |
| 2026-03-06 | Ms. Mardi C. DierExec. VP & CFO | -1.34k | 574.96k | Automatic Disposition | 425.08 - 437.65 | 0.00 | -100.00% |
| 2026-03-06 | Mr. William J. SiboldCEO, President & Director | -1.66k | 718.32k | 売り | 431.94 | 105.91k | -1.55% |
| 2026-03-06 | Ms. Shannon KelleyExec. VP, Chief Legal Officer & Corporate Secretary | -360.00 | 155.50k | 売り | 431.94 | 1.82k | -16.51% |
| 2026-03-06 | Ms. Carole HuntsmanExec. VP & Chief Commercial Officer | -419.00 | 180.98k | 売り | 431.94 | 427.00 | -49.53% |
| 2026-03-06 | Dr. Rebecca A. TaubFounder, Senior Scientific & Medical Advisor and Director | -491.00 | 212.08k | 売り | 431.94 | 441.03k | -0.11% |
| 2026-03-02 | Ms. Mardi C. DierExec. VP & CFO | -1.18k | 505.39k | 売り | 427.21 | 1.04k | -53.31% |
| 2026-02-23 | Dr. Richard S. LevyIndependent Director | 2.50k | 18.40k | Derivative Exercise and Retained Stock | 7.36 | 26.98k | 10.21% |
| 2026-01-26 | Dr. Richard S. LevyIndependent Director | 4.00k | 65.84k | Derivative Exercise and Retained Stock | 16.46 | 24.48k | 19.53% |
| 2026-01-26 | Ms. Carole HuntsmanExec. VP & Chief Commercial Officer | -340.00 | 167.42k | 売り | 492.42 | 9.12k | -3.59% |
| 2026-01-26 | Ms. Carole HuntsmanExec. VP & Chief Commercial Officer | -570.00 | 281.92k | Automatic Disposition | 494.59 | 9.12k | -5.88% |
| 2026-01-26 | Mr. William J. SiboldCEO, President & Director | -1.58k | 776.55k | 売り | 492.42 | 104.31k | -1.49% |
| 2026-01-26 | Dr. Rebecca A. TaubFounder, Senior Scientific & Medical Advisor and Director | -647.00 | 318.60k | 売り | 492.42 | 440.43k | -0.15% |
| 2026-01-20 | Ms. Shannon KelleyExec. VP, Chief Legal Officer & Corporate Secretary | -263.00 | 129.07k | 売り | 490.77 | 1.38k | -15.98% |
| 2026-01-20 | Ms. Shannon KelleyExec. VP, Chief Legal Officer & Corporate Secretary | -429.00 | 215.10k | Automatic Disposition | 501.40 | 1.38k | -23.68% |
| 2026-01-20 | Dr. Rebecca A. TaubFounder, Senior Scientific & Medical Advisor and Director | -2.24k | 1.10M | 売り | 490.77 | 439.63k | -0.51% |
| 2026-01-09 | Dr. Paul A. FriedmanDirector | -24.80k | 12.57M | Derivative Exercise and Sale | 15.80 - 551.24 | 954.00k | - |
| 2026-01-09 | Dr. Rebecca A. TaubFounder, Senior Scientific & Medical Advisor and Director | -18.65k | 9.45M | Derivative Exercise and Sale | 15.80 - 551.24 | 436.87k | - |
| 2025-12-10 | Dr. Paul A. FriedmanDirector | -24.80k | 13.30M | Derivative Exercise and Sale | 15.80 - 555.39 | 954.00k | - |
| 2025-12-10 | Dr. Rebecca A. TaubFounder, Senior Scientific & Medical Advisor and Director | -18.65k | 10.00M | Derivative Exercise and Sale | 15.80 - 555.39 | 1.11M | - |
| 2025-12-10 | Dr. Rebecca A. TaubFounder, Senior Scientific & Medical Advisor and Director | -5.46k | 0.00 | Other Disposition | - | 1.11M | -0.49% |
| 2025-12-03 | Mr. William J. SiboldCEO, President & Director | 47.60k | 0.00 | Derivative Exercise and Retained Stock | - | 102.82k | 86.20% |
| 2025-12-03 | Mr. William J. SiboldCEO, President & Director | -2.40k | 1.38M | Derivative Exercise and Sale | 575.34 | 102.82k | - |
| 2025-12-02 | Ms. Mardi C. DierExec. VP & CFO | -4.17k | 1.36M | Derivative Exercise and Sale | 251.63 - 596.19 | 0.00 | - |
| 2025-11-21 | Ms. Carole HuntsmanExec. VP & Chief Commercial Officer | -1.96k | 1.08M | 売り | 547.27 - 564.57 | 0.00 | -100.00% |
| 2025-11-13 | Dr. Richard S. LevyIndependent Director | -8.50k | 4.31M | Derivative Exercise and Sale | 7.36 - 530.21 | 20.48k | - |
| 2025-11-05 | Mr. Kenneth M. Bateインサイダー | -16.58k | 4.63M | Derivative Exercise and Sale | 9.45 - 490.98 | 1.91k | - |
| 2025-09-09 | Mr. William J. SiboldCEO, President & Director | -7.28k | 3.24M | 売り | 445.63 | 55.22k | -11.65% |
| 2025-08-21 | Mr. William J. SiboldCEO, President & Director | -7.62k | 3.05M | Automatic Disposition | 400.03 - 401.00 | 50.00k | -13.22% |
| 2025-08-18 | Baker Bros. Advisors LP法人 | 151.71k | 56.70M | 買い | 353.88 - 392.24 | 1.94M | 8.46% |
| 2025-08-18 | 667, L.P.法人 | 13.98k | 5.22M | 買い | 353.88 - 392.24 | 198.99k | 7.55% |
| 2025-08-18 | Ms. Shannon KelleyExec. VP, Chief Legal Officer & Corporate Secretary | -458.00 | 164.27k | 売り | 358.66 | 0.00 | -100.00% |
| 2025-08-18 | Ms. Shannon KelleyExec. VP, Chief Legal Officer & Corporate Secretary | -846.00 | 315.36k | Automatic Disposition | 369.64 - 376.62 | 0.00 | -100.00% |
| 2025-08-15 | Mr. Kenneth M. Bateインサイダー | -10.00k | 3.49M | Derivative Exercise and Sale | 16.46 - 368.56 | 1.91k | - |
| 2025-08-11 | Dr. Paul A. FriedmanDirector | -175.98k | 62.79M | Derivative Exercise and Sale | 9.45 - 374.38 | 954.00k | - |
| 2025-08-11 | Dr. Rebecca A. TaubFounder, Senior Scientific & Medical Advisor and Director | -46.46k | 16.07M | Derivative Exercise and Sale | 9.45 - 359.71 | 1.12M | - |
| 2025-07-18 | Dr. Rebecca A. TaubFounder, Senior Scientific & Medical Advisor and Director | -1,000.00 | 340.56k | Derivative Exercise and Sale | 9.45 - 350.01 | 1.12M | - |
| 2025-07-18 | Dr. Paul A. FriedmanDirector | -1.40k | 476.81k | Derivative Exercise and Sale | 9.45 - 350.03 | 954.00k | - |
| 2025-07-16 | Dr. Paul A. FriedmanDirector | -28.88k | 9.93M | Derivative Exercise and Sale | 9.45 - 356.62 | 954.00k | - |
| 2025-07-16 | Dr. Rebecca A. TaubFounder, Senior Scientific & Medical Advisor and Director | -29.10k | 10.00M | Derivative Exercise and Sale | 9.45 - 356.52 | 1.12M | - |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。